Invitae Corporation, a leading player in the genetic information industry, is headquartered in the United States. Founded in 2010, the company has rapidly established itself as a pioneer in genetic testing and diagnostics, focusing on areas such as hereditary cancer, cardiovascular conditions, and rare diseases. With a commitment to making genetic information accessible, Invitae offers a comprehensive suite of services, including advanced genetic testing and interpretation, which are distinguished by their accuracy and affordability. The company has achieved significant milestones, including the integration of cutting-edge technology to enhance patient care and support clinical decision-making. Recognised for its innovative approach, Invitae holds a strong market position, serving healthcare providers and patients across various regions. Its dedication to improving health outcomes through genetic insights continues to set it apart in the evolving landscape of personalised medicine.
How does Invitae Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Invitae Corporation's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2021, Invitae Corporation, headquartered in the US, reported total carbon emissions of approximately 3,519,000 kg CO2e, which includes 512,000 kg CO2e from Scope 1 emissions and about 3,071,000 kg CO2e from Scope 2 emissions. The Scope 1 emissions breakdown indicates that 12,000 kg CO2e stemmed from mobile combustion, while the majority, approximately 500,000 kg CO2e, was attributed to stationary combustion. Despite these figures, Invitae has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. There are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges noted in their reports. Furthermore, the company does not inherit emissions data from any parent or related organizations, indicating that all reported figures are solely from Invitae Corporation itself. As the company continues to operate within the biotechnology sector, it is essential for Invitae to consider establishing measurable climate commitments to align with industry standards and expectations for sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Invitae Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

